Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 15.17 as of Tuesday, July 28, 2026.
Forward PE Ratio (15.17) = Close Price ($72.06) / Consensus Forward EPS ($4.63)
FORWARD PE RATIO
15.17
SECTOR MEDIAN · HEALTHCARE
18.59
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-18.42%
vs the sector median at left
The Cooper Companies, Inc.
Market Cap
$14.05B
Forward PE Ratio
15.17
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.05B | 15.17 |
| Solventum Corporation (SOLV)vs › | $14.92B | 12.29 |
| DaVita Inc. (DVA)vs › | $15.37B | 15.88 |
| Baxter International Inc. (BAX)vs › | $12.59B | 12.14 |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 14.78 |
| Revvity, Inc. (RVTY)vs › | $12.44B | 20.62 |
| Medpace Holdings, Inc. (MEDP)vs › | $15.94B | 33.60 |
| Insulet Corp. (PODD)vs › | $11.60B | 25.47 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | 20.20 |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 37.47 |
Trailing P/E
59.6
reported TTM EPS
Forward P/E
15.2
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.63 implies +292.4% EPS growth vs the reported trailing $1.18.
At today's $72.06 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-10-31 | $4.63 | $4.61 – $4.67 | 11 | 15.6x |
| 2027-10-31 | $5.02 | $4.94 – $5.09 | 11 | 14.4x |
| 2028-10-31 | $5.47 | $4.56 – $6.21 | 8 | 13.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
